Biotech · Private company
T-MAXIMUM Pharmaceutical Inc
Track this companyFree. Adds T-MAXIMUM Pharmaceutical Inc to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3Phase 2 · Brain Metastases From Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3Phase 2 · Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- The METAMAX Study: MT027 Allogeneic CAR-T for Brain Metastases From Advanced Solid TumorsPHASE2 · NOT_YET_RECRUITING · started Dec 30, 2027ClinicalTrials.gov NCT07897799 · fetched Nov 12, 2026
- The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent GliomaPHASE2 · NOT_YET_RECRUITING · started Nov 30, 2026ClinicalTrials.gov NCT07386002 · fetched Nov 12, 2026